OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Substance Abuse Treatment is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine	93
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19	83
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic	77
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder	75
A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose	71
Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19	66
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings	60
Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study	57
Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study	57
A systematic review of stigma interventions for providers who treat patients with substance use disorders	55
Peer recovery coaches in general medical settings: Changes in utilization, treatment engagement, and opioid use	45
Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19	44
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns	44
Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond	42
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island	42
Telehealth sustains patient engagement in OUD treatment during COVID-19	41
Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19	41
Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms	39
Impacts of COVID-19 on residential treatment programs for substance use disorder	38
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?	37
The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19	36
Appointment wait-times and arrival for patients at a low-barrier access addiction clinic	36
Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?	35
Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic	34
Family involvement in treatment and recovery for substance use disorders among transition-age youth: Research bedrocks and opportunities	33

Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment	32
Adolescent substance use: Challenges and opportunities related to COVID-19	31
COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings	31
Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health	30
Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities	30